Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study
Prior detection of precursor conditions (MGUS or SMM) is associated with improved overall survival in multiple myeloma patients compared to those diagnosed de novo.
Improved survival with earlier detection supports targeted surveillance of high‑risk individuals and could influence screening and monitoring guidelines for precursor plasma‑cell disorders.
Bizonyítékszint: Korai humán adat. Kis vagy feltáró emberi adat.
Kapcsolódó jelek
- Multiple Myeloma Clinical Trials & Emerging Therapies
- A single‑cell atlas of multiple myeloma defines malignant archetypes and proliferative states
- S2209: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)
- Nanomedicine-Empowered CAR‑T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy
- Genomic profiling enables personalized strategies to overcome drug resistance in multiple myeloma